Recent research has focused on the development of targeted therapies and immunotherapies that offer new hope for patients with both chronic respiratory illnesses and cancer. Advances in genetic profiling and personalized medicine are enabling more precise treatment strategies. Additionally, ongoing studies are exploring the potential of anti-inflammatory drugs to reduce cancer risk in patients with chronic respiratory conditions.
